NIKKEI 225
27,885.87 +65.47 (+0.24%) HANG SENG
19,441.18 -77.11 (-0.40%) CRUDE OIL
74.57 +0.32 (+0.43%) GOLD FUTURES
1,783.20 +0.80 (+0.04%) DOW
33,596.34 -350.76 (-1.03%) BTC-GBP
14,053.15 +6.24 (+0.04%)
Relief Therapeutics Holding AG (0QKQ.L)
| Previous close | 0.0290 |
| Open | 0.0285 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 0.0285 - 0.0291 |
| 52-week range | 0.0285 - 0.0291 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 180,674 |
| Beta (5Y monthly) | -13.94 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0100 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- EQS Group
APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival
Relief Therapeutics Holding SA / Key word(s): MiscellaneousAPR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival 21.11.2022 / 07:00 CET/CESTAPR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film FestivalGeneva, Switzerland, November 21, 2022 – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTD) (“Relief”), a Swiss, commercial-stage biophar
- EQS Group
Relief Therapeutics Files Amendment No. 1 to its Registration Statement on Form F-1 with the U.S. Securities and Exchange Commission
Relief Therapeutics Holding SA / Key word(s): Miscellaneous16-Nov-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics Files Amendment No. 1 to its Registration Statement on Form F-1 with the U.S. Securities and Exchange Commission Geneva, Switzerland, November 16, 2022 – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTD) (“Relief”), announced today that it has filed Amen
- EQS Group
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement Agreements
Relief Therapeutics Holding SA / Key word(s): Miscellaneous14-Nov-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement AgreementsGeneva, Switzerland and Radnor, Pennsylvania, November 14, 2022 – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTD) ("Relief"), and NRx Pharmaceuticals, Inc. (
